a strong trendp=0.058
There was also a strong trend towards better overall survival in the CDKN2A(p16) positive group (p=0.058).
There was also a strong trend towards better overall survival in the CDKN2A(p16) positive group (p=0.058).
There was a trend towards better overall survival for p16 positive tumors as well but this did not reach statistical significance (p = 0.058, Figure 4 ).
Furthermore, CDKN1A(p21) expression was associated with better overall patient survival (p=0.045), while CDKN2A(p16) expression showed a trend toward better overall survival, in univariate analysis.